切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (05) : 609 -611. doi: 10.3877/cma.j.issn.1674-6902.2019.05.015

短篇论著

非小细胞肺癌并发糖尿病患者uPA异常表达的影响因素分析
孔冉冉1, 马跃峰1, 马震川1, 孙良章1, 张丹杰1, 李少民1, 姜建涛1,()   
  1. 1. 710004 西安,西安交通大学第二附属医院胸外科
  • 收稿日期:2019-03-21 出版日期:2019-10-20
  • 通信作者: 姜建涛
  • 基金资助:
    陕西省重点研发计划项目资助(2017SF-130)

Influence factors of abnormal uPA expression in patients with non­small cell lung cancer complicated with diabetes

Ranran Kong1, Yuefeng Ma1, Zhenchuan Ma1   

  • Received:2019-03-21 Published:2019-10-20
引用本文:

孔冉冉, 马跃峰, 马震川, 孙良章, 张丹杰, 李少民, 姜建涛. 非小细胞肺癌并发糖尿病患者uPA异常表达的影响因素分析[J]. 中华肺部疾病杂志(电子版), 2019, 12(05): 609-611.

Ranran Kong, Yuefeng Ma, Zhenchuan Ma. Influence factors of abnormal uPA expression in patients with non­small cell lung cancer complicated with diabetes[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(05): 609-611.

表1 阳性组与阴性组临床资料比较[n(%)]
表2 影响NSCLC并发糖尿病患者uPA异常表达的多因素回归分析结果
1
Tong Y, Yue J, Mao M, et al. Recombinant nematode anticoagulant protein c2 inhibits cell invasion by decreasing uPA expression in NSCLC cells[J]. Oncology reports, 2015, 33(4): 1815-1822.
2
乐胜兵,吴密璐. 非小细胞肺癌靶向治疗研究进展[J]. 现代肿瘤医学,2016, 24(5): 840-843.
3
Della Corte CM, Ciaramella V, Di Mauro C, et al. Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells[J]. Oncotarget, 2016, 7(4): 4265.
4
Shen Z, Chen B, Gan X, et al. Methylation of neurofilament light polypeptide promoter is associated with cell invasion and metastasis in NSCLC[J]. Biochem Biophys Res Communicat, 2016, 470(3): 627-634.
5
贾晓琼,孙秋颖,温珍平. TFPT在非小细胞肺癌中的表达和意义[J]. 中国医师进修杂志,2018, 41(2): 149-152.
6
Li Z, Guo C, Liu X, et al. TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression[J]. Oncotarget, 2016, 7(38): 62224.
7
de Aberasturi A L, Redrado M, Villalba M, et al. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients[J]. Cancer Letters, 2016, 370(2): 165-176.
8
Liu K, Xu SH, Chen Z, et al. TRPM7 overexpression enhances the cancer stem cell-like and metastatic phenotypes of lung cancer through modulation of the Hsp90α/uPA/MMP2 signaling pathway[J]. BMC Cancer, 2018, 18(1): 1167.
9
杨 宏,韩 震,何 敏,等. 非小细胞肺癌EGFR突变与临床特性的相关性分析[J]. 内蒙古医科大学学报,2017, 39(4): 341-345.
10
高 歌,邓立力. 非小细胞肺癌EGFR、KRAS、ALK基因突变与不同转移器官分布的相关性研究进展[J]. 中国肺癌杂志,2018, 21(7): 536-542.
11
Rajasinghe LD, Hutchings M, Gupta SV. Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach[J]. Metabolites, 2019, 9(3): 50.
12
Van Der Steen N, Pauwels P, Gil-Bazo I, et al. cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance[J]. Cancers, 2015, 7(2): 556-573.
13
王晓莉,葛晓松,刘彦魁,等. EGFR/ALK/ROS1三联检测在非小细胞肺癌中的临床意义[J]. 临床与实验病理学杂志,2018, 34(10): 77-79.
14
Banys-Paluchowski M, Witzel I, Aktas B, et al. The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer[J]. Scientific Reports, 2019, 9(1): 2318.
15
王 嘉,吕艳超,许浩然,等. 非小细胞肺癌组织中AKT1、PDCD4蛋白表达变化及意义[J]. 山东医药,2016, 56(6): 16-18.
16
Lu J J, Guo H, Gao B, et al. Prognostic value of urokinase plasminogen activator system in non-small cell lung cancer: A systematic review and meta-analysis[J]. Molecular Clin Oncol, 2018, 8(1): 127-132.
17
熊 娟,朱 静,张毅敏,等. Treg MMP-9及UPA mRNA在肺癌中的表达及临床意义[J]. 浙江临床医学,2017, 19(5): 798-800.
18
Hsia TC, Yu CC, Hsiao YT, et al. Cantharidin impairs cell migration and invasion of human lung cancer NCI-H460 cells via UPA and MAPK signaling pathways[J]. Anticancer Res, 2016, 36(11): 5989-5997.
19
Ostheimer C, Evers C, Bache M, et al. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume[J]. Strahlenth Onkolog, 2018, 194(6): 539-551.
20
Zhang H, Peng C, Huang H, et al. Effects of amiloride on physiological activity of stem cells of human lung cancer and possible mechanism[J]. Biochem Biophys Res Communicat, 2018, 504(1): 1-5.
21
Chang JH, Lai SL, Chen WS, et al. Quercetin suppresses the metastatic ability of lung cancer through inhibiting snail-dependent Akt activation and snail-independent ADAM9 expression pathways[J]. Biochem Biophys Acta (BBA)-Molecular Cell Res, 2017, 1864(10): 1746-1758.
22
Pavón MA, Arroyo-Solera I, Céspedes MV, et al. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy[J]. Oncotarget, 2016, 7(35): 57351.
23
Banys-Paluchowski M, Witzel I, Aktas B, et al. The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer[J]. Sci Rep, 2019, 9(1): 2318.
24
王学谦,林洪生. uPA/uPAR与恶性肿瘤关系的研究进展[J]. 医学研究杂志,2016, 45(9): 14-17.
25
赵文斌,范睿睿,马天宇. 血清CA125和HE4联合uPA及其受体在卵巢肿瘤中的表达和意义[J]. 中国慢性病预防与控制,2017, 25(25): 849.
26
Peng X, Zhou D, Wang X, et al. Matrine suppresses proliferation and invasion of SGC7901 cells through inactivation of PI3K/Akt/uPA pathway[J]. Ann Clin Lab Sci, 2016, 46(5): 457-462.
27
Woo JK, Jung HJ, Park JY, et al. Daurinol blocks breast and lung cancer metastasis and development by inhibition of focal adhesion kinase (FAK)[J]. Oncotarget, 2017, 8(34): 57058.
28
Wu JY, Lin SS, Hsu FT, et al. Fluoxetine inhibits DNA repair and NF-κB-modulated metastatic potential in non-small cell lung cancer[J]. Ant Res, 2018, 38(9): 5201-5210.
29
Wu M H, Chiu Y F, Wu W J, et al. Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression[J]. Environment Toxicol, 2018, 33(12): 1237-1244.
30
Hosseini N, Khoshnazar A, Saidijam M, et al. Zerumbone Suppresses Human Colorectal Cancer Invasion and Metastasis via Modulation of FAk/PI3k/NFκB-uPA Pathway[J]. Nutrit Cancer, 2019, 71(1): 159-171.
[1] 何金梅, 尹立雪, 谭静, 张文军, 王锐, 任梅, 廖明娇. 超声心肌做功技术对2型糖尿病患者潜在左心室心肌收缩功能损伤的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1029-1035.
[2] 王珏, 陈赛君, 贲志飞, 詹锦勇, 徐开颖. 剪切波弹性成像联合极速脉搏波技术评估颈动脉弹性对糖尿病性视网膜病变的预测价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 636-641.
[3] 王洁, 丁泊文, 尹健. 糖尿病性乳腺病52例临床分析[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 285-289.
[4] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[5] 张健, 刘小龙, 查天建, 姚俊杰, 王傑. 富含血小板血浆联合异种脱细胞真皮基质修复糖尿病足缺血性创面的临床效果[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 503-506.
[6] 赵雅玫, 谢斌, 陈艳, 吴健. 抗生素骨水泥联合负压封闭引流对糖尿病足溃疡临床疗效的荟萃分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 427-433.
[7] 叶弘, 吕婧喆, 钟良军. 白藜芦醇治疗牙周炎和糖尿病的新进展[J]. 中华口腔医学研究杂志(电子版), 2023, 17(05): 376-380.
[8] 李琛, 张惟佳, 潘亚萍. 牙周炎与系统性疾病之间关系的应用思考:2022年EFP和WONCA欧洲分部联合研讨会共识报告的解读及启示[J]. 中华口腔医学研究杂志(电子版), 2023, 17(05): 322-327.
[9] 中国康复医学会器官移植康复专业委员会. 成人实体器官移植后糖尿病管理专家共识[J]. 中华移植杂志(电子版), 2023, 17(04): 205-220.
[10] 徐天亮, 程干思, 吴亚平, 龚荣, 胡洁, 段群娣, 李承慧. 奥希替尼联合安罗替尼二线治疗转移性NSCLC的疗效分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 520-522.
[11] 魏婷婷, 胡小红, 龚自强, 熊鹿. 老年非小细胞肺癌组织ARPC2表达及与预后关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 584-586.
[12] 黄岩, 刘晓巍, 杨春玲, 兰烨. 急性胰腺炎合并糖尿病患者的临床特征及血糖代谢与病情严重度的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 439-442.
[13] 张政赢, 鞠阳, 刘晓宁. 二甲双胍对2型糖尿病患者大肠腺瘤术后复发的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 485-488.
[14] 薛念余, 张盛敏, 吴凌恒, 沙蕾, 童揽月, 沈崔琴, 李朝军, 杜联芳. 研究血清胆红素对2型糖尿病患者心脏结构发生改变前心肌功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1004-1009.
[15] 谢国晓, 赵凌霞, 薛雪花. 慢性病管理模式在糖尿病社区管理中的应用[J]. 中华临床医师杂志(电子版), 2023, 17(05): 587-590.
阅读次数
全文


摘要